International Journal of

Womens Health and WellnessISSN: 2474-1353

Archive

 Open Access DOI:10.23937/2474-1353/1510095

Influence of Maternal BMI and Maternal Weight Gain during Pregnancy on Maternal and Perinatal Outcome - A Retrospective Data Analysis of Pregnancies during 2004 and 2014

Kundu S, Kaukemueller L, von Kaisenberg C, Hillemanns P, Soergel P, Kuehnle E and Staboulidou I

Article Type: Original Article | First Published: May 06, 2019

The aim of this study was to describe the influence of maternal pregnancy body mass index (BMI) and maternal weight gain during pregnancy on perinatal and neonatal outcomes. Retrospective analysis of singleton pregnancies > 37 weeks of gestation delivered between 2004 and 2014. Fetal anomalies and intrauterine deaths have been excluded....

 Open Access DOI:10.23937/2474-1353/1510094

Unmasking Hidden Recurrent Cancers using FMTVDM/BEST: The Fleming Cancer Hypothesis

Richard M Fleming, PhD, MD, JD, Matthew R. Fleming, BS, Tapan K Chaudhuri, MD, William C Dooley, MD and Andrew McKusick, BS Pharm

Article Type: Commentary | First Published: April 24, 2019

Prior to FMTVDM/BEST Imaging, diagnostic testing was limited to looking for breast cancer either using "qualitative" imaging defining disease as being present or absent, or semiquantitative methods which are also limited to the same yes you have breast cancer or no you don't interpretation. These imaging methods include mammography, ultrasound, CT, MRI, as well as other SPECT/Planar and PET imaging approaches and as such are associated with sensitivity and specificity problems. These tests are f...

 Open Access DOI:10.23937/2474-1353/1510093

FMTVDM/BEST Imaging Equally Applicable for Male Breast Cancer

Richard M Fleming, PhD, MD, JD, Matthew R. Fleming, BS, Tapan K Chaudhuri, MD, William C Dooley, MD and Andrew McKusick, BS Pharm

Article Type: Commentary | First Published: April 10, 2019

Prior to FMTVDM/BEST Imaging, diagnostic testing was limited to looking for breast cancer either using "qualitative" imaging defining disease as either present or absent, or semiquantitative methods which is also limited to the same yes you have breast cancer or no you don’t interpretation. These imaging methods include mammography, ultrasound, CT, MRI, as well as other SPECT/Planar and PET imaging approaches and as such are associated with sensitivity and specificity problems. These tests are...

 Open Access DOI:10.23937/2474-1353/1510092

FMTVDM/BEST Imaging for Women with Breast Implants and Dense Breasts

Richard M Fleming, PhD, MD, JD, Matthew R Fleming, BS, Tapan K Chaudhuri, MD, William C Dooley, MD, and Andrew Mc Kusick, BS Pharm

Article Type: Commentary | First Published: April 08, 2019

Prior to FMTVDM/BEST Imaging, diagnostic testing was limited to looking for breast cancer either using "qualitative" imaging defining disease as either present or absent, or semiquantitative methods which is also limited to the same yes you have breast cancer or no you don't interpretation. These imaging methods include mammography, ultrasound, CT, MRI, as well as other SPECT/Planar and PET imaging approaches and as such are with associated sensitivity and specificity problems. These tests are f...

 Open Access DOI:10.23937/2474-1353/1510091

HR-MRI of the Breast at Intervals of Maximum 24 Months: Influence on Tumor Stage at the Time of Diagnosis

Uwe Fischer, M Hollstein, S Luftner-Nagel, F Baum and S Wienbeck

Article Type: Original Article | First Published: April 04, 2019

Tumor size, the histology and immunhistochemical parameters as well as the lymph node status at the time of diagnosis have a relevant influence on the prognosis and the long time-survival of breast cancer. In this context, invasive carcinomas under 10 mm in size, which most often exhibit a N0-lymph node status, have an excellent 10-year-tumor-free survival rate of 98%. With respect to intraductal breast tumors, this rate increases to 100% if adequate therapy is performed. Self-examination and me...

Volume 5
Issue 2